Abstract

HTA214 Distributional Cost-Effectiveness Analysis of Lung Cancer Treatments From an NHS England Perspective

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call